A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma

NCT04187404 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

70

Enrollment

INDUSTRY

Sponsor class

Stopped Strategic decision

Conditions

Adrenocortical Carcinoma
Pheochromocytoma
Paraganglioma

Interventions

BIOLOGICAL: EO2401
BIOLOGICAL: Nivolumab

Sponsor

Enterome